Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: nail psoriasis

2015 Treatment Recommendations for Psoriatic Arthritis

Arthritis & Rheumatology  |  April 28, 2016

Psoriatic arthritis (PsA) is remarkably diverse in presentation and course. To assist clinicians in its management, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) published treatment recommendations in 2009 based on a systematic evidence review. To be clinically relevant, such recommendations must be dynamic, and significant developments in PsA pathophysiology and disease assessment, particularly regarding the important contribution of comorbidities coupled with major therapeutic advances, necessitated an update of the GRAPPA recommendations…

Filed under:ConditionsPsoriatic ArthritisResearch Rheum Tagged with:Arthritis & RheumatologyClinical Practice GuidelinesGRAPPAGuidelinesPsoriatic ArthritisResearch

Case Study in Dermatology: Tender Papules on Elbows, Hands in RA

Drew Kurtzman, MD, & Timothy McCalmont, MD, with Ruth Ann Vleugels, MD, MPH, & Joseph F. Merola, MD, MMSc  |  February 17, 2016

The Case A 41-year-old woman was referred to the dermatology clinic for a three-month history of tender lesions on her elbows and around the joints of her hands. Her medical history was notable for seropositive, non-erosive rheumatoid arthritis (RA), which was being treated with 5 mg pred­nisone daily, 10 mg methotrexate weekly by mouth, 200…

Filed under:ConditionsRheumatoid Arthritis Tagged with:case reportClinicalDermatologyDiagnosispapulespatient careRheumatoid arthritisrheumatologyTreatment

Biosimilar Drugs for RA Studied in Multiple Trials

Michele B. Kaufman, PharmD, BCGP  |  August 17, 2015

Etanercept Biosimilars A number of Phase 3 trials are ongoing for etanercept biosimilars.1 One evaluation identified three trials in rheumatoid arthritis (RA) patients and one in psoriasis patients. The psoriatic arthritis trial evaluated PASI as a primary endpoint and the following secondary endpoints: PASI50, PASI75, PASI90, PASI score, laboratory values, ECG, adverse events (AEs), injection…

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:Biosimilarsclinical trialsDrugsoutcomeRheumatoid arthritisrheumatologySafety

2014 ACR/ARHP Annual Meeting: Psoriatic Arthritis

Mary Beth Nierengarten  |  February 1, 2015

Clinical manifestations, approaches to diagnosis, treatment

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)ClinicalDiagnosisNierengartenPsoriatic ArthritisTreatment

Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Jonathan S. Hausmann, MD  |  January 1, 2014

Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

Filed under:Axial SpondyloarthritisConditionsPediatric ConditionsRheumatoid Arthritis Tagged with:anti-inflammatoryautoinflammatoryClinicalDiagnosisdrugfeverlabsMethotrexatepatient carePediatricprednisoneReactive arthritistocilizumabweight loss

Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

Jonida Cote, DO, Thomas Harrington, MD, Alicia Meadows, DO, Fan Lin, MD, and Androniki Bili, MD, MPH  |  November 1, 2013

Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:Psoriatic ArthritisSarcoidosisTherapiesTreatmentTumor Necrosis Factor–Alpha Inhibitor

Rheumatology Drug Updates

Michele D. Kaufman, PharmD, BSc, RPh  |  September 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:acetaminophenadalimumabDrugsFDASafety

Patient Fact Sheet: Juvenile Idiopathic Arthritis

Staff  |  May 9, 2012

Several types of arthritis fall under the JIA heading. This inflammation begins before patients reach the age of 16 years, and may involve one or many joints and cause other symptoms such as fevers, rash, and eye inflammation.

Filed under:Career DevelopmentConditionsEducation & TrainingFrom the CollegeProfessional TopicsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)inflammationJIAJuvenile idiopathic arthritispatient carepatient educationPediatricsPsoriatic ArthritisRheumatoid arthritisrheumatologist

Treatment Patterns and Trends for Spondylarthropathies

Vanessa Caceres  |  April 6, 2012

Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesPsoriatic Arthritis Tagged with:ACR/ARHP Annual MeetingAnkylosing Spondylitisanti-inflammatorydrugGlucocorticoidsMethotrexatepatient carePsoriatic ArthritisReactive arthritisRheumatoid arthritis

A Unique Structure for Tackling Psoriatic Disease

Gretchen Henkel  |  June 13, 2011

GRAPPA brings together a group of highly motivated physicians to address these complex disorders

Filed under:ConditionsProfilesPsoriatic ArthritisResearch Rheum Tagged with:GRAPPAPsoriasisPsoriatic ArthritisResearch

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences